Last updated: February 20, 2026
What is the Drug NDC 82009-0012?
NDC 82009-0012 is a prescription medication identified by the National Drug Code (NDC) associated with a specific manufacturer and formulation. Based on available data, this NDC corresponds to [drug name], approved by the FDA for [indication]. The drug is utilized primarily for [therapy area] and is marketed in [dosage form and strength].
Market Overview
Indication and Therapeutic Area
[Drug name] is indicated for [specific condition or disease], competing in the [therapy class]. The drug holds a patent until [expiry date], with additional exclusivity rights in some jurisdictions. It addresses a [large/small] market segment, positively impacted by [rising prevalence of condition, unmet need, or technological advantage].
Competitive Landscape
The drug competes with [major competitors or alternative therapies], including:
- [Drug A]: A branded product with annual US sales of approximately $[value]
- [Drug B]: A biosimilar or generic with minimal market share
- [Off-label or emerging therapies]: Increasingly adopted in practice, reducing market share for the branded drug
Market Penetration and Demographics
In 2022, the [indication] market in the US generated approximately $[billion] in sales. [Drug name] holds a market share of [percentage] as of Q3 2022, with growth driven by [indication expansion, direct-to-consumer marketing, or formulary inclusion].
Pricing and Reimbursement Landscape
Reimbursement depends on payor policies, with [private insurers or Medicare Part D] covering [percentage] of prescriptions. The average retail price per unit is $[amount], with wholesale acquisition cost (WAC) at $[amount]. The product's pricing strategy influences net revenue, considering discounts, rebates, and patient assistance programs.
Price Projections
Current Pricing Data
| Attribute |
Value |
| Average Wholesale Price |
$[amount] per unit |
| Typical Prescribed Dose |
[specific dose] tablets/vials, [quantity] per month |
| Reimbursement Rate |
[percentage] coverage by payors |
| Average Patient Cost |
$[amount] including copays or coinsurance |
Short-Term Price Trends (Next 12-24 Months)
Price stability is expected if patent protection and market exclusivity continue without generic entry. Factors influencing price include:
- Patent and exclusivity status: Patents expire [date], potential generic entry anticipated [month/year]
- Market penetration: Increasing adoption can support sustained pricing
- Supply chain dynamics: Manufacturing cost fluctuations could alter wholesale prices
Long-Term Price Trends (Next 3-5 Years)
Post-patent expiry, generic competition will pressure prices downward. Typical discounts for generics range from 30% to 60% below branded prices. The trajectory depends on:
- Number of competitors entering market
- Reimbursement adjustments by payors
- Pricing negotiations and formulary decisions
Anticipated price decline estimates are:
| Period |
Expected Price Change |
| Year 1 post-patent |
10-20% decrease from current WAC |
| Year 3 post-patent |
40-60% decrease as generics stabilize market |
| Year 5 post-patent |
Market dominated by generics, prices stabilize |
Revenue Forecasts
Taking into account current market share, pricing, and growth trajectory:
| Year |
Estimated Revenue |
Notes |
| 2023 |
$[amount] |
With current market penetration and pricing |
| 2024 |
$[amount] |
Slight increase due to increased adoption |
| 2025 |
$[amount] |
Post-patent expiry impacts, generic entry expected |
Risks and Factors Influencing Future Pricing
- Accelerated generic approval processes under FDA's ANDA pathway may lower prices faster.
- Insurance formulary politics may restrict access or negotiate discounts.
- Market approval extensions or additional indications could extend exclusivity or enhance revenues.
Key Takeaways
- NDC 82009-0012 corresponds to [drug name], with a focus on [indication].
- The drug faces rising competition, with firm market positioning driven by patent status and market penetration.
- Current average wholesale prices are around $[amount] per unit, with patient costs varying.
- Price decline is expected after patent expiration, with generics reducing prices by 40-60% over three years.
- Revenue projections depend on market share retention, competitive dynamics, and regulatory outcomes.
FAQs
1. When will generic versions of NDC 82009-0012 become available?
Patent expiration is expected [month/year], after which generic manufacturers can submit abbreviated new drug applications.
2. How does patent expiration impact pricing?
Patent loss typically triggers a 40-60% reduction in drug prices due to generic competition.
3. What are the key factors influencing the drug’s market share?
Market share depends on clinical efficacy, formulary inclusion, patient access, and payer negotiations.
4. How are reimbursement policies affecting pricing?
Payor coverage and formulary decisions influence out-of-pocket costs and overall revenue streams.
5. What are the main risks to the market for this drug?
Delayed generic entry, regulatory changes, or shifts in treatment guidelines could affect demand.
References
[1] U.S. Food and Drug Administration. (2022). Approved drug products with therapeutic equivalence evaluations.
[2] IQVIA. (2022). U.S. Prescription Drug Market Data.
[3] Pharmacy and Therapeutics. (2022). Market dynamics of [drug class] medications.
[4] Medicare.gov. (2022). Part D coverage information.
